The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
HER2+ gastric cancer patient demographics and implications for clinical trial enrollment.
Paulina Zelenay McAtee
Research Funding - PPD Inc.
Ashley Erickson Simmons
No relevant relationships to disclose
Marie-Edith Anne Bonneterre
No relevant relationships to disclose
Dirk J. Reitsma
Employment or Leadership Position - PPD Inc.
Jaikrishna Balkissoon
No relevant relationships to disclose
Peter J. Wyld
No relevant relationships to disclose
Angelena Moseley
No relevant relationships to disclose
Austin James Combest
No relevant relationships to disclose